Half Yearly Report and Accounts
| Stock | Fisher & Paykel Healthcare Corporation Ltd (FPH.ASX) |
|---|---|
| Release Time | 26 Nov 2025, 7:30 a.m. |
| Price Sensitive | Yes |
Fisher & Paykel Healthcare delivers strong growth for the first half
- 14% increase in operating revenue to $1.09 billion
- 39% increase in net profit after tax to $213.0 million
- 17% increase in Hospital operating revenue to $692.2 million
Fisher & Paykel Healthcare Corporation Limited has announced its results for the first half of the 2026 financial year, which ended 30 September 2025. Total operating revenue was $1.09 billion, an increase of 14% over the first half of the prior financial year, or 12% in constant currency. Net profit after tax was $213.0 million, an increase of 39% over the first half of the prior financial year, or 28% in constant currency. The company saw broad-based strength across the Hospital consumables portfolio during a period of lower seasonal respiratory hospitalisations, and in Homecare, its latest range of masks for treating obstructive sleep apnea has performed well. For the Hospital product group, first-half revenue was $692.2 million, a 17% increase over the same period last year, or 15% in constant currency. Sales of hardware grew 21% in constant currency, and Hospital new applications consumables revenue increased 16% in constant currency. For the Homecare product group, first-half revenue was $395.9 million, an increase of 10% on the first half of last year, or 8% in constant currency. Continuous improvement activities and other efficiency gains contributed to gross margin amidst the recent impact of US tariffs on Hospital products sourced from New Zealand.
The company now expects full-year operating revenue in the range of approximately $2.17 billion to $2.27 billion and full-year net profit after tax in the range of approximately $410 million to $460 million.
The company's second-half Hospital consumables growth can be influenced by year-on-year variations in the Northern Hemisphere winter respiratory season, and the company does not have any additional insights into that impact at present. Available data indicates that last winter was a historically strong season, and so a similar season this year would be pushing the result towards the top end of guidance.